We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Eli Lilly, Exxon Mobil, Lowe's, General Electric and Anthem
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 14, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly and Company (LLY - Free Report) , Exxon Mobil Corporation (XOM - Free Report) , Lowe's Companies, Inc. (LOW - Free Report) , General Electric Company (GE - Free Report) and Anthem, Inc. .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Eli Lilly, Exxon Mobil and Lowe's
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Exxon Mobil, and Lowe's. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Eli Lilly have outperformed the Zacks Large Cap Pharmaceuticals industry in the year to date period (+43.5% vs. +13.2%) on the back of strong demand for drugs like Trulicity and Taltz. A solid portfolio of new drugs in diabetes, autoimmune diseases and cancer is another positive.
The company has been regularly adding promising new pipeline assets through major business development deals. Generic competition, however, for several drugs, rising pricing pressure in the United States, and price cuts in international markets like China, Japan and Europe remain as major top-line headwinds.
Exxon Mobil shares have gained +63% over the past year against the Zacks Integrated International Oil industry’s gain of +47.6%. The Zacks analyst believes that major discoveries in the Stabroek Block have enhanced prospects for ExxonMobil's upstream businesses.
In deep water Guyana resources, the firm announced new oil discoveries at Pinktail, Uaru-2, Longtail-3, and Whiptail. Improved realized oil and natural gas prices coupled with higher chemical margins have been boosting the company’s profit levels. Lower margins due to a weak refining business have been weighing on its downstream operations though.
Shares of Lowe's have gained +19.4% in the last six months against the Zacks Building Products - Retail industry’s gain of +15.4%. The Zacks analyst believes that the company remains well positioned to capitalize on demand for the home improvement market backed by investments in technology, merchandise category and strength in Pro business.
Lowe's second-quarter fiscal 2021 results benefited from the strong execution of strategies to meet broad-based demand. The company’s new total home strategy that includes providing complete solutions for various types of home repair and improvement needs also bodes well. Market risks including foreign currency exchange rates and intense competition are major concerns though.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Eli Lilly, Exxon Mobil, Lowe's, General Electric and Anthem
For Immediate Release
Chicago, IL – September 14, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly and Company (LLY - Free Report) , Exxon Mobil Corporation (XOM - Free Report) , Lowe's Companies, Inc. (LOW - Free Report) , General Electric Company (GE - Free Report) and Anthem, Inc. .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Eli Lilly, Exxon Mobil and Lowe's
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Exxon Mobil, and Lowe's. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Eli Lilly have outperformed the Zacks Large Cap Pharmaceuticals industry in the year to date period (+43.5% vs. +13.2%) on the back of strong demand for drugs like Trulicity and Taltz. A solid portfolio of new drugs in diabetes, autoimmune diseases and cancer is another positive.
The company has been regularly adding promising new pipeline assets through major business development deals. Generic competition, however, for several drugs, rising pricing pressure in the United States, and price cuts in international markets like China, Japan and Europe remain as major top-line headwinds.
(You can read the full research report on Eli Lilly here >>>)
Exxon Mobil shares have gained +63% over the past year against the Zacks Integrated International Oil industry’s gain of +47.6%. The Zacks analyst believes that major discoveries in the Stabroek Block have enhanced prospects for ExxonMobil's upstream businesses.
In deep water Guyana resources, the firm announced new oil discoveries at Pinktail, Uaru-2, Longtail-3, and Whiptail. Improved realized oil and natural gas prices coupled with higher chemical margins have been boosting the company’s profit levels. Lower margins due to a weak refining business have been weighing on its downstream operations though.
(You can read the full research report on Exxon Mobil here >>>)
Shares of Lowe's have gained +19.4% in the last six months against the Zacks Building Products - Retail industry’s gain of +15.4%. The Zacks analyst believes that the company remains well positioned to capitalize on demand for the home improvement market backed by investments in technology, merchandise category and strength in Pro business.
Lowe's second-quarter fiscal 2021 results benefited from the strong execution of strategies to meet broad-based demand. The company’s new total home strategy that includes providing complete solutions for various types of home repair and improvement needs also bodes well. Market risks including foreign currency exchange rates and intense competition are major concerns though.
(You can read the full research report on Lowe's here >>>)
Other noteworthy reports we are featuring today include General Electric and Anthem.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.